GlassScriptPhysician profile
Mark Spencer Hansen
NPI 1467787226
$2,738.98
in general payments reported to CMS, 2019-2025
11 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2023: $2,177 · 2024: $171 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,950 · Food and Beverage: $514 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,950.00 |
| Food and Beverage | $514.25 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $1,950.00 | 2023 | Iyuzeh |
| Glaukos Corporation | $289.07 | 2023-2025 | Gts100-Glaukos Istent Trabecular Micro-Bypass Stent System, Istent Trabecular Micro-Bypass Stent System, Idosetr |
| Rxsight INC | $176.42 | 2024-2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Quidel Corporation | $103.62 | 2019 | |
| Ocular Therapeutix, INC. | $100.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $44.33 | 2019-2023 | |
| Abbvie INC. | $33.65 | 2024 | |
| Harrow Eye, LLC | $24.64 | 2025 | Vevye |
| Biotissue Holdings INC. | $16.44 | 2023 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.